4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000024
Chief Accounting Officer sold 282 shares at $14.95 ($4,216)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-01 | Sale : show line 1 in the form 10b5-1 | −282 | $14.95 | $4,216 | 11,596 | D |
| Open-market sales · 282 sh · avg $14.95 · $4,216 | ||||||
Loading xslF345X05/wk-form4_1701811666.xml…